A Study on Assessment of Relationship between Blood Glucose and Serum Lipids in Patients of Dyslipidemia Receiving Atorvastatin

Journal Title: Journal of Medical Science And clinical Research - Year 2017, Vol 5, Issue 2

Abstract

Background: Atorvastatin and Lovastatin the most commonly used lipid lowering impair glucose tolerance; Simvastatin reduces insulin secretion while Pravastatin has been shown to increase adiponectin, improving insulin sensitivity and inhibiting gluconeogenesis. For these reasons, in February 2012 the United States Food and Drug Administration mandated labeling changes for all statins except Pravastatin. Objective of the study was to study the relationship between blood glucose and serum lipids in patients of Dyslipidemia receiving Atorvastatin Methods: A prospective, single center study that was conducted in of total of 60 subjects. Newly diagnosed patients suffering from dyslipidemia, according to NCEP ATP III Guidelines (National Cholesterol Education Program, Adult Treatment Panel III).These are divided in 2 groups (n= 30 each). GROUP 1-patients having dyslipidemia with type 2 Diabetes Mellitus and GROUP 2-patients having dyslipidemia without Diabetes Mellitus. Conclusion: With the results of present study 10 mg/day of Atorvastatin for 6 months did not affect FBG or PPBG in Non-diabetic patients significantly, but there was a significant deterioration in the blood glucose control - fasting and post-prandial, in the diabetic patients after 6 months and 3 months of drug use respectively. Atorvastatin 10 mg is an effective hypolipidemic drug and has adequate lipid lowering effects in diabetic and non-diabetics

Authors and Affiliations

Gauri Hari Kasabe

Keywords

Related Articles

Bacteriological Profile and C Reactive Protein Level of Neonatal Septicemia

Neonatal Sepsis is a life threatening emergency, and any delay in the treatment may cause death. Because of the importance of this problem, the objective of the present study was to determine the etiological agents and C...

HIV and Tuberculosis: the impact goes beyond those infected with HIV/AIDS

Background & objectives: Tuberculosis is said to be one of the commonest opportunistic infection in patients with HIV/ AIDS. In this study the clinical profile of tuberculosis in patient with HIV infection /AIDS and to s...

A Study of Lipid Profile in Diabetic Patients

Background: Dyslipidemia is one of the common disorders seen in most of the diabetes patients. Objective: To study the lipid profile in patients with diabetes mellitus. Methods: The study was carried out at a diagnostic...

Diagnostic Role of FOB in Radiological Hilar and Parahilar Shadow of Patients Reporting at Tertiary Care Centre

Fiberoptic bronchoscopy (FOB) is an important procedure for diagnosis of different respiratory problems. The present study was conducted to evaluate the diagnostic role of FOB in Hilar & Parahilar shadows and also to eva...

Malaria Control Strategies Adopted by Residents of Ikirike Community in Enugu State

Malaria is highly endemic in Nigeria; it poses a major challenge to the country as it impedes human development. The economic loss to Nigeria due to malaria is estimated at 132 billion naira annually due to loss of man h...

Download PDF file
  • EP ID EP274920
  • DOI -
  • Views 68
  • Downloads 0

How To Cite

Gauri Hari Kasabe (2017). A Study on Assessment of Relationship between Blood Glucose and Serum Lipids in Patients of Dyslipidemia Receiving Atorvastatin. Journal of Medical Science And clinical Research, 5(2), 17887-17897. https://europub.co.uk/articles/-A-274920